Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 18, 2022 - Issue 4
Submit an article Journal homepage
412
Views
3
CrossRef citations to date
0
Altmetric
Review

Drug–drug interactions involving antipsychotics and antihypertensives

Catalin Adrian Buzeaa Department 5 Internal Medicine, Carol Davila’ University of Medicine and Pharmacy, Bucharest, Romania;b Cardiology, Clinical Hospital Colentina, Bucharest, RomaniaORCID Iconhttps://orcid.org/0000-0002-3365-9149View further author information
ORCID Icon,
Lorena Dimac Department of Fundamental Disciplines and Clinical Prevention, Faculty of Medicine, Transilvania University of Brasov, Brașov, RomaniaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4406-9304View further author information
ORCID Icon,
Christoph U. Correlld Department of Child and Adolescent Psychiatry, Charite Universitaetsmedizin, Berlin, Germany;e Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA;f Department of Psychiatry, Zucker Hillside Hospital, Northwell Health System, Glen Oaks, NY, USAORCID Iconhttps://orcid.org/0000-0002-7254-5646View further author information
ORCID Icon &
Peter Manug Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA;h Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA;i Medical Services, South Oaks Hospital, Northwell Health System, Amityville, NY, USAView further author information
Pages 285-298 | Received 24 Feb 2022, Accepted 31 May 2022, Published online: 14 Jun 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Catalin Adrian Buzea, Peter Manu, Lorena Dima & Christoph U. Correll. (2022) Drug–drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugs. Expert Opinion on Drug Metabolism & Toxicology 18:11, pages 729-744.
Read now
Amedeo Lonardo. The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management. A narrative review focusing on principal risk modifiers. Expert Review of Clinical Pharmacology 0:0.
Read now

Articles from other publishers (1)

Cvetka Bačar Bole, Katja Nagode, Mitja Pišlar, Aleš Mrhar, Iztok Grabnar & Tomaž Vovk. (2023) Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021. Medicina 59:2, pages 284.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.